These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 32472199
21. Fundus autofluorescence in patients with pseudoxanthoma elasticum. Sawa M, Ober MD, Freund KB, Spaide RF. Ophthalmology; 2006 May; 113(5):814-20.e2. PubMed ID: 16650677 [Abstract] [Full Text] [Related]
22. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks. Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F. Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865 [Abstract] [Full Text] [Related]
23. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS. Kim J, Dalziel D. Retin Cases Brief Rep; 2021 May 01; 15(3):246-250. PubMed ID: 30048402 [Abstract] [Full Text] [Related]
31. Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks. Esen E, Sizmaz S, Demircan N. Indian J Ophthalmol; 2015 Jul 01; 63(7):616-8. PubMed ID: 26458482 [Abstract] [Full Text] [Related]
32. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum. Battaglia Parodi M, Romano F, Marchese A, Arrigo A, Llorenç V, Cicinelli MV, Bandello F, Adán A. Graefes Arch Clin Exp Ophthalmol; 2019 Feb 01; 257(2):273-278. PubMed ID: 30470876 [Abstract] [Full Text] [Related]
33. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Iacono P, Battaglia Parodi M, Selvi F, Parravano MC, Chiaravalloti A, Varano M, Bandello F. Retina; 2017 Oct 01; 37(10):1931-1941. PubMed ID: 28033235 [Abstract] [Full Text] [Related]
34. Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up. Schiano Lomoriello D, Parravano MC, Chiaravalloti A, Varano M. Eur J Ophthalmol; 2009 Oct 01; 19(1):151-3. PubMed ID: 19123166 [Abstract] [Full Text] [Related]
35. Fundus autofluorescence in Pseudoxanthoma elasticum. Finger RP, Charbel Issa P, Ladewig M, Götting C, Holz FG, Scholl HP. Retina; 2009 Oct 01; 29(10):1496-505. PubMed ID: 19823106 [Abstract] [Full Text] [Related]
36. Prognostic factors for intravitreal conbercept in the treatment of choroidal neovascularization secondary to pathological myopia. Wang D, Wu K, Li X, Chen L, Huang W. Int Ophthalmol; 2024 Jun 22; 44(1):253. PubMed ID: 38907787 [Abstract] [Full Text] [Related]
37. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Ladas ID, Kotsolis AI, Ladas DS, Niskopoulou M, Georgalas I, Papakonstantinou D, Rouvas AA. Retina; 2010 Sep 22; 30(8):1185-9. PubMed ID: 20539257 [Abstract] [Full Text] [Related]
38. [Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks]. Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D. Ophthalmologe; 2007 Apr 22; 104(4):325-8. PubMed ID: 17334745 [Abstract] [Full Text] [Related]
39. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness. Shi X, Wei W, Zhang C. Chin Med J (Engl); 2014 Apr 22; 127(12):2279-85. PubMed ID: 24931242 [Abstract] [Full Text] [Related]
40. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks. Tetikoglu M, Sagdik HM, Aktas S, Ozcura F. Eye (Lond); 2016 Jun 22; 30(6):894-5. PubMed ID: 26939555 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]